Criteria for melanocytic lesions in LC-OCT
- PMID: 38727525
- DOI: 10.1111/jdv.20079
Criteria for melanocytic lesions in LC-OCT
Abstract
Background: Line-field confocal optical coherence tomography (LC-OCT) is an emerging diagnostic tool with imaging depth reaching ~400 μm and a novel three-dimensional (3D) cube providing cellular resolution. As far as we are aware, there are only a limited number of papers that have reported diagnostic criteria for melanocytic lesions using this technique, and none of them have been multicentric.
Objectives: Our aim was to establish the diagnostic criteria for melanocytic lesions using LC-OCT and identify the most significant architectural and cytologic features associated with malignancy.
Methods: A retrospective evaluation of 80 consecutive melanocytic lesions from a prospective multicentric data set spanning three European centres was conducted. We excluded facial, acral and mucosal lesions from the study. Dermoscopic and LC-OCT images were evaluated by a consensus of four observers. Multivariate logistic regression with backward elimination was employed.
Results: The main melanoma diagnostic criteria include detecting >10 pagetoid cells in 3D acquisition, irregular 3D epidermal architecture, disrupted dermoepidermal junction (DEJ) and clefting. Significant risk factors were irregular 3D epidermal architecture, >10 pagetoid cells, dendritic cells at DEJ without underlying inflammation. Novel malignancy criteria in vertical view were DEJ disruption and clefting around atypical melanocyte nests. Exclusive melanoma features were epidermal nests, epidermal consumption, dense dermal nests with atypia. Protective features in the absence of any malignancy indicators were DEJ ring pattern, cobblestone, elongated rete ridges (vertical), well-defined DEJ and wave pattern (vertical).
Conclusions: A series of diagnostic criteria for the identification of melanocytic lesions with LC-OCT have been established. Validation of these criteria in clinical practice through future studies is essential to further establish their utility.
© 2024 European Academy of Dermatology and Venereology.
References
REFERENCES
-
- Dubois A, Levecq O, Azimani H, Davis A, Ogien J, Siret D, et al. Line‐field confocal time‐domain optical coherence tomography with dynamic focusing. Opt Express. 2018;26(26):33534–33542.
-
- Dubois A, Levecq O, Azimani H, Siret D, Barut A, Suppa M, et al. Line‐field confocal optical coherence tomography for high‐resolution noninvasive imaging of skin tumors. J Biomed Opt. 2018;23(10):1–9.
-
- Davis A, Levecq O, Azimani H, Siret D, Dubois A. Simultaneous dual‐band line‐field confocal optical coherence tomography: application to skin imaging. Biomed Opt Express. 2019;10(2):694–706.
-
- Lenoir C, Diet G, Cinotti E, Tognetti L, Orte Cano C, Rocq L, et al. Line‐field confocal optical coherence tomography of sebaceous hyperplasia: a case series. J Eur Acad Dermatol Venereol. 2021;35(8):e509–e511.
-
- Lenoir C, Cinotti E, Tognetti L, Orte Cano C, Diet G, Miyamoto M, et al. Line‐field confocal optical coherence tomography of actinic keratosis: a case series. J Eur Acad Dermatol Venereol. 2021;35(12):e900–e902.
Publication types
MeSH terms
Grants and funding
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
- European Development Regional Fund 'A way to achieve Europe' ERDF
- PI15/00716/Spanish Fondo de Investigaciones Sanitarias
- PI15/00956/Spanish Fondo de Investigaciones Sanitarias
- PI18/00419/Spanish Fondo de Investigaciones Sanitarias
- AGAUR 2017_SGR_1134/Catalan Government, Spain
- LSHC-CT-2006-018702/European Commission
- CA83115/The National Cancer Institute (NCI) of the US National Institute of Health (NIH)
- 201331-30/Fundació La Marató de TV3
- GCB15152978SOEN/Fundación Científica de la Asociación Española Contra el Cáncer
- CERCA Programme/Generalitat de Catalunya
- Esther Koplowitz Center, Barcelona
LinkOut - more resources
Full Text Sources